New gold standard for type 1 diabetes

The US Endocrine Society has backed the use of continuous glucose monitoring as the gold standard in treatment for adults with type 1 diabetes in a new guideline on the use of the devices.

The updated guideline includes evidence from a number of recent studies on continuous subcutaneous insulin infusion therapy (CSII) and continuous glucose monitoring (CGM), the Endocrine Society taskforce says.

“Scientific evidence supports the use